Lithium-induced diabetes insipidus: manic symptoms, brain and electrolyte correlates, and chlorothiazide treatment.
D001714:Bipolar Disorder / Q000188:drug therapy* / Q000503:physiopathology; D002740:Chlorothiazide / Q000494:pharmacology / Q000627:therapeutic use*; D003919:Diabetes Insipidus / Q000139:chemically induced* / Q000188:drug therapy; D005069:Evaluation Studies as Topic; D005071:Evoked Potentials; D005260:Female; D006760:Hospitalization; D006801:Humans; D007671:Kidney Concentrating Ability / Q000187:drug effects; D008094:Lithium / Q000008:administration & dosage / Q000009:adverse effects* / Q000097:blood / Q000627:therapeutic use; D008875:Middle Aged; D011141:Polyuria / Q000139:chemically induced / Q000188:drug therapy; D012964:Sodium; D013003:Somatosensory Cortex / Q000503:physiopathology; D014667:Vasopressins / Q000494:pharmacology; D014882:Water-Electrolyte Balance
D014667:Vasopressins; D002740:Chlorothiazide; D008094:Lithium; D012964:Sodium